Home › Funds › Handelsbanken Fonder AB › EW
Handelsbanken Fonder AB position in EW
EDWARDS LIFESCIENCES CORP · Health Care
Handelsbanken Fonder AB reported holding 1,542,016 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$133.1M, representing 0.37% of its reported portfolio and ranking #41 among its reported holdings. Handelsbanken Fonder AB has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Handelsbanken Fonder AB's EW position evolved
Handelsbanken Fonder AB first disclosed a stake in EW in Q3 2023 at 1,324,087 shares (US$91.7M). The position peaked in Q2 2024 at 1,869,977 shares, worth US$172.7M. Across 13 filings, Handelsbanken Fonder AB increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,542,016 shares valued at US$133.1M. Notable position changes include a 57% trim in Q4 2024 (shares fell 2% over the following quarter), a 62% increase in Q2 2025 (shares were roughly flat over the following quarter), a 232% increase in Q4 2025 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.32M | $91.73M | New |
| Q4 2023 | 1.61M | $122.78M | Add |
| Q1 2024 | 1.58M | $150.78M | Reduce |
| Q2 2024 | 1.87M | $172.73M | Add |
| Q3 2024 | 1.13M | $74.79M | Reduce |
| Q4 2024 | 490.17K | $36.29M | Reduce |
| Q1 2025 | 224.41K | $16.27M | Reduce |
| Q2 2025 | 364.32K | $28.49M | Add |
| Q3 2025 | 362.99K | $28.23M | Hold |
| Q4 2025 | 1.20M | $102.60M | Add |
| Q1 2026 | 1.26M | $101.14M | Add |
| Q2 2026 | 1.54M | $139.42M | Add |
| Q3 2026 | 1.54M | $133.11M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- Belvedere Trading LLC 3.30M sh · $25.63B · Q3 2026
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M sh · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M sh · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.09M sh · $525.69M · Q3 2026
More on Handelsbanken Fonder AB
FAQ
How long has Handelsbanken Fonder AB held EW?
Handelsbanken Fonder AB has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Handelsbanken Fonder AB's current position in EW?
As of Q3 2026, Handelsbanken Fonder AB holds 1.54M shares of EW (EDWARDS LIFESCIENCES CORP), valued at $133.11M, representing 0.37% of its reported portfolio and ranking #41.
Has Handelsbanken Fonder AB been buying or selling EW?
In the latest 13F filing (Q3 2026), Handelsbanken Fonder AB held unchanged its position in EW. The position peaked in Q2 2024 at 1.87M shares.
Which other funds hold EW?
Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.